Pulmonary Hypertension Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Hypertension; Chronic Obstructive Pulmonary Disease Intervention: Drug: Tadalafil Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
Condition: Pulmonary Arterial Hypertension Interventions: Drug: Selexipag; Drug: Riociguat; Device: CardioMEMS pulmonary artery pressure monitor; Device: Confirm Rx Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; University of Glasgow; University of Sheffield; University of Newcastle Upon-Tyne; University of Cambridge Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
